Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials (2009)
- Authors:
- Autor USP: VOLTARELLI, JULIO CESAR - FMRP
- Unidade: FMRP
- DOI: 10.1186/1758-5996-1-19
- Subjects: DIABETES MELLITUS; CÉLULAS-TRONCO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Diabetology & Metabolic Syndrome
- ISSN: 1758-5996
- Volume/Número/Paginação/Ano: v. 1, art. 19, 2009
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
COURI, Carlos Eduardo Barra e VOLTARELLI, Julio Cesar. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetology & Metabolic Syndrome, v. 1, 2009Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-1-19. Acesso em: 25 abr. 2024. -
APA
Couri, C. E. B., & Voltarelli, J. C. (2009). Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetology & Metabolic Syndrome, 1. doi:10.1186/1758-5996-1-19 -
NLM
Couri CEB, Voltarelli JC. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials [Internet]. Diabetology & Metabolic Syndrome. 2009 ; 1[citado 2024 abr. 25 ] Available from: https://doi.org/10.1186/1758-5996-1-19 -
Vancouver
Couri CEB, Voltarelli JC. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials [Internet]. Diabetology & Metabolic Syndrome. 2009 ; 1[citado 2024 abr. 25 ] Available from: https://doi.org/10.1186/1758-5996-1-19 - Graft - versus - host diseases
- CD8+/DR+/CD25 - T-lymphocytes associated with marrow graft failure
- Funcao de cd2 e cd18 na citoxidade celular dependente de anticorpos (adcc)
- Expansion of a subset of tcr 'GAMA' / 'RO' human lymphocytes from various lymphoids organs cultured with recombinant il-2
- Matinal tailler (mtc) and lymphocyte activited tittler (lat) functions in human chagas disease
- In vitro primary immune response by human lymphocytes against leishmania braziliensis promastigotes
- Reforma no ensino medico
- Fas/Fas-ligand expression on lymphocytes subsets in chronic myelogenous leukemia patients after allogenic
- The use stem cells for the treatment of autoimmune diseases
- CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non-hodgkin's lymphoma
Informações sobre o DOI: 10.1186/1758-5996-1-19 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
